Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
PT-141 structure

PT-141

Cosmetic & Sexual
Approved Research
90%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 1.75 mg
Range 0.5 - 2 mg
Max Daily 2 mg

Pharmacokinetics

Half-Life 2.5 hrs
Onset 45 min
Peak 2.0 hrs
Duration 6.0 hrs
Bioavailability 95%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Nasal
Injection Sites Abdomen, Thigh
Needle Gauge 29-31G
Syringe Type Insulin
Timing 45min before activity

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Concentration 5000 mcg/mL
Stability 30 days refrigerated
Vial Sizes 10 mg

Special Instructions

Take 45+ minutes before desired effect. Do not use more than once per 24 hours. Maximum 8 doses per month (FDA guidance).